Multi-Location Sleep Diagnostic Testing Platform

This opportunity represents a well-established and profitable multi-location Independent Diagnostic Testing Facility (IDTF) specializing in the diagnosis and treatment of Obstructive Sleep Apnea (OSA). The practice is accredited by the American Academy of Sleep Medicine and operates across two fully equipped locations, offering both in-lab polysomnography and home sleep testing (HST) using state-of-the-art diagnostic equipment. The combination of clinical credibility and advanced capabilities positions the business as a trusted provider within its market. The Company benefits from a diversified and stable payer mix, with approximately 54% of revenue derived from commercial payers and approximately 45% from government sources, alongside minimal exposure to self-pay. Medicare alone represents over 30% of total revenue, providing a consistent and reliable patient base. The practice maintains in-network contracts with major commercial carriers, including Blue Cross Blue Shield, UnitedHealthcare, Humana, Cigna, and Aetna, creating a strong competitive advantage and meaningful barrier to entry for new market participants. Operations are supported by a dual-modality testing model that includes both in-lab and at-home sleep studies, enabling the business to balance higher reimbursement procedures with scalable, higher-margin services. The Company has developed a strong and consistent referral network from physicians and healthcare providers, ensuring steady patient flow without reliance on significant marketing spend. Staffing consists of seven full-time and one part-time employee, all of whom are experienced and expected to remain with the business following a transaction, supporting continuity and ease of transition. With two operational locations and existing infrastructure in place, the platform is well-positioned for growth and expansion. Opportunities exist to increase utilization of home sleep testing, expand geographically, and potentially integrate adjacent services within the sleep care continuum. The seller is committed to supporting a smooth and seamless transition, making this a turnkey acquisition opportunity for strategic buyers or investors seeking entry or expansion in the growing sleep medicine sector.